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ABSTRACT 
Multiple sclerosis (MS) is an inflammatory, demyelinating disease that can affect several 
areas of the central nervous system. Damage along the auditory pathway can alter its 
integrity significantly. Therefore, it is important to investigate the auditory pathway, from 
the brainstem to the cortex, in individuals with MS. Objective: The aim of this study was 
to characterize auditory evoked potentials in adults with MS of the remittent-recurrent 
type. Method: The study comprised 25 individuals with MS, between 25 and 55 years, 
and 25 age- and gender-matched healthy controls (research and control groups). Subjects 
underwent audiological and electrophysiological evaluations. Results: Statistically significant 
differences were observed between the groups regarding the results of the auditory 
brainstem response and the latency of the Na and P300 waves. Conclusion: Individuals with 
MS present abnormalities in auditory evoked potentials indicating dysfunction of different 
regions of the central auditory nervous system.
Key words: auditory evoked potentials, auditory brain stem evoked potentials, P300 event-
related potentials, multiple sclerosis.
Potenciais evocados auditivos e esclerose múltipla 
RESUMO
A esclerose múltipla é uma doença inflamatória desmielinizante que pode se 
desenvolver em diversas regiões do sistema nervoso central. O comprometimento da 
via auditiva central pode alterar significativamente a integridade desta e, portanto, 
a investigação desta região em indivíduos com esclerose múltipla, desde o tronco 
encefálico até o córtex, torna-se importante. Objetivo: Caracterizar os resultados dos 
potenciais evocados auditivos em adultos com esclerose múltipla do tipo remitente-
recorrente. Método: Foram submetidos às avaliações audiológica e eletrofisiológica 25 
indivíduos pertencentes ao grupo controle e 25 ao grupo pesquisa, com idades entre 
25 e 55 anos. Resultados: Verificou-se diferença estatisticamente significante entre os 
grupos quanto à ocorrência de resultados normais e alterados no potencial evocado 
auditivo de tronco encefálico e latências das ondas Na e P300. Conclusão: Indivíduos 
com esclerose múltipla apresentam alterações nos potenciais evocados auditivos, 
indicando comprometimento de diferentes regiões do sistema nervoso auditivo central.
Palavras-chave: potenciais evocados auditivos, potenciais evocados auditivos do tronco 
encefálico, potencial evocado P300, esclerose múltipla. 
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Multiple sclerosis (MS) is a progressive, 
inflammatory, demyelinating disease that 
was first identified by Jean Charcot in 1860. 
MS is caused by the destruction of the my-
elin sheath by autoantibodies and the di-
rect action of immune cells via the infiltra-
tion of lymphocytes and monocytes. The 
main functions of myelin are to ensheath 
and electrically isolate the axons allowing 
nerve impulses to be conducted at high 
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speeds within the brain parenchyma. Therefore, chang-
es in brain functions observed in individuals with MS are 
a result of impairment in the transmission of informa-
tion caused by the destruction of the myelin nerve wrap1.
MS can affect any region of the central nervous sys-
tem. Therefore, special attention must be given to the 
central auditory nervous system because hearing func-
tion is dependent on nervous system’s integrity. Thus, au-
diological diagnoses based only on conventional audio-
logical evaluation do not consider the many changes that 
occur along the central auditory pathway, some of which 
are not clinically manifested2.
Auditory evoked potentials (AEP) reflect the neuro-
electric activity within the auditory pathway, from the 
auditory nerve to the cerebral cortex, in response to an 
acoustic stimulus or event. The most studied AEP are the 
brainstem auditory evoked potential (BAEP), the audi-
tory middle latency response (AMLR) and the cognitive 
potential (P300).
BAEP, which consists of seven waves generated by one 
or more structures along the auditory pathway, assesses 
the integrity of the auditory pathway from the auditory 
nerve to the brainstem. AMLR, consisting of a series of 
waves that appear after the BAEP, reflects the activation 
of several subcortical structures. P300 is an endogenous, 
event-related potential and its generation involves skills 
such as attention, auditory discrimination, memory and 
semantic perspective. It may be more correlated to the 
degree of global auditory dysfunction than any specific 
diagnosis because its results are affected by a variety of 
disorders that alter cognition3.
The appearance of sclerotic plaques along the audi-
tory pathway significantly alters its integrity. Therefore, 
it is important to investigate the functioning of the cen-
tral auditory nervous system in individuals with MS. Sev-
eral studies have been performed to investigate the AEP 
in subjects with MS. The results of these studies varied 
but have mainly indicated BAEP abnormalities in MS pa-
tients4-7. Furthermore, researchers have emphasized the 
use of P300 as a clinical differential in patients with MS as 
P300 is effective in detecting cognitive dysfunctions thus 
increasing the chances of neuropsychological interven-
tion with an emphasis on cognitive rehabilitation8-11.
AEP, besides its usefulness in identifying lesions in the 
auditory pathway, is useful in monitoring changes in the 
auditory pathway. Schochat et al.7 state that although MRI 
has advanced the diagnosis of MS, it is feasible to use the 
AEP resources with precision in the follow-up treatment 
of pre-established profiles and in the diagnosis of new le-
sions that might develop, including those lesions that are 
clinically silent.
Due to the considerations presented, this study aimed 
to characterize AEP of short (BAEP) and middle (AMLR) 
latencies and P300 in adults with MS of the remittent-
recurrent type and normal hearing. These results were 
compared to the results obtained in individuals with nor-
mal hearing and no history of neurological alteration.
METHOD
Institutional review board approval for this study was 
obtained from CAPPesq - HC/FMUSP and was registered 
under protocol number 274/06.
The inclusion criteria for the control group (CG) 
were history of normal neurological development, nor-
mal hearing thresholds, absence of psychiatric diagnoses, 
no complaints of tinnitus, and no auditory processing dis-
orders. For the research group (RG), the inclusion criteria 
were medical diagnosis of MS of the remittent-recurrent 
type based on the criteria proposed by Poser et al.9, nor-
mal hearing thresholds, and no outbreak for at least six 
months before the recording of auditory evoked poten-
tials. All the participants signed an inform consent.
The two groups were composed of 25 individuals each 
with 19 females and six males aged between 25 and 55 
years (mean age of 35.16 years for the CG and of 34.88 
years for the RG). Participants in the RG were referred by a 
neurologist. At the time of data collection the RG partici-
pants were undergoing medical follow-ups. Participants in 
the CG were age- and gender-matched to RG participants.
Initially, an anamnesis was performed with each par-
ticipant to obtain personal data related to the history of 
the disease (MS), use of medications and hearing devel-
opment. Information gathered during the anamnesis was 
confirmed by neurologists. All participants of the RG un-
derwent MRI and received interferon beta 1a drug treat-
ment. Of the 25 subjects evaluated, besides the character-
istic lesions of MS in the central semi-oval center, two had 
sclerotic plaques in the regions that generate the brainstem 
auditory evoked potentials. It was determined from the 
subjects’ medical histories that the average duration of dis-
ease was four years and three months. Patients were evalu-
ated for MS12 outbreaks up until the time of data collection 
and the results are as follows: two had one outbreak (8%), 
five had two outbreaks (20%), four had three outbreaks 
(16%), eight had four outbreaks (32%), four had five out-
breaks (16%), one had six outbreaks (4%) and one had sev-
en outbreaks (4%). According to the EDSS scale, eight pa-
tients (32%) were in the range zero, six (24%) in range one, 
eight in range two (32%) and three (12%) in range three.
An audiological evaluation was performed in both 
groups to select the individuals with normal hearing. The 
evaluation consisted of external ear canal inspection with 
the Heine® otoscope, pure tone audiometry (250 to 8000 
Hz) and speech audiometry (speech reception threshold 
and speech recognition index) performed with a GSI-61 
audiometer, as well as acoustic imittance measures (tym-
Arq Neuropsiquiatr 2010;68(4)
530
Auditory evoked potentials in MS
Matas et al.
panometry and acoustic reflex research, at frequencies of 
500, 1000, 2000 and 4000 Hz) performed with the middle 
ear analyzer GSI-33. 
Electrophysiological evaluation consisted of record-
ing BAEP, AMLR and P300. These evaluations were con-
ducted on Masbe equipment - Contronic® and the ATC-
plus 2.1® software installed on a computer.
Initially, the skin of each individual was cleansed with 
abrasive paste and the electrodes were attached with elec-
trolytic paste and adhesive tape and positioned according 
to the International Electrode System (IES) 10-2013. The 
value of the electrode impedance was checked prior to 
use and maintained below 5 kOhms. The acoustic stimu-
lus was presented through a pair of TDH-39® headphones. 
The selection of parameters for the acoustic stimulus 
that was used in these experiments to record the auditory 
evoked potentials was based on the most frequently uti-
lized parameters in the specialized literature.
For BAEP, the acoustic stimulus used was the click, 
rarefaction polarity, presented monaurally at 80 dBnHL, 
at a rate of 19.9 clicks per second (total of 2000 stimuli) 
with low-pass filter of 3000 Hz and high-pass filter of 100 
Hz. Two recordings were obtained at the same intensity 
to ensure the trace reproducibility. The latencies of waves 
I, III, V and interpeaks I-III, III-V, I-V were marked using 
the standard values proposed by Hall 3. 
The click stimulus was used to obtain the AMLR. The 
stimulus was presented monaurally at 70 dBnHL, at a rate 
of 9.9 clicks per second (total of 1000 stimuli) with a low-
pass filter of 150 Hz and a high-pass filter of 10 Hz. The 
values of Na-Pa amplitude at the derivations C3/A1, C4/
A2, C3/A2 and C4/A1 were analyzed. The Na-Pa am-
plitude values were analyzed using a two-by-two design 
comparing the ipsilateral and contralateral values14. The 
Pa and Na wave latency values were also analyzed. The 
values proposed by McGee et al.15 were used as normal-
ity criteria.
The acoustic stimulus tone burst was used to obtain 
the P300. The 75 dBnHL stimuli were randomly present-
ed by the computer at the frequencies of 1000 Hz (fre-
quent stimulus) and 1500 Hz (rare stimulus) at a rate of 
1.1 stimuli per second with low-pass filters of 30 Hz and 
high-pass filters of 1 Hz. The rare stimulus consisted of 
15% to 20% of the total of the 300 stimuli. The individ-
ual was instructed to identify the rare stimulus by rais-
ing his/her hand every time it was heard.16 The presence 
and absence of this potential and the latency value of the 
P300 wave were marked according to the normal values 
proposed by McPherson17.
Results that were not in accordance with the criteria 
previously described were considered abnormal. The in-
dividual was considered abnormal when at least one of 
the ears and/or sides presented abnormality. The abnor-
malities were classified according to each auditory evoked 
potential as follows: 
For BAEP, the abnormalities were divided according 
to their location as follows: lower brainstem (LB) - in-
creased latencies of waves III and V and interpeaks I-III 
e I-V; higher brainstem (HB) - increased latencies of wave 
V and interpeaks I-V e III-V with normal values of laten-
cies of waves I and III; and both - LB and HB types oc-
curring concurrently in the same individual.
For AMLR, with respect to the Na-Pa amplitude, ab-
normalities were classified as electrode effect, ear effect 
or both (the latter used when the individual presented 
both types of abnormalities, electrode effect and ear ef-
fect, occurring concurrently). The electrode effect is char-
acterized by the presence of a difference greater than 50% 
when comparing the magnitude of measures obtained on 
C3/A1 and C4/A1 with the measures obtained on C3/
A2 and C4/A2. The electrode effect is, therefore, an ab-
normality that can be detected in the AMLR and is not 
linked to poor contact of the electrode. The ear effect is 
characterized by the presence of a difference greater than 
50% when comparing the magnitude of the measures ob-
tained on C3/A1 and C3/A2 with the measures obtained 
on C4/A1 and C4/A2. The Pa and Na wave latency val-
ues were considered abnormal when the values exceed-
ed the adopted normal value. This abnormality was clas-
sified as latency delay.
The abnormalities observed on P300 were classified as 
latency delay, absence or both (the latter was used when 
the individual presented both types of abnormalities, la-
tency delay and absence, occurring concurrently with one 
type of abnormality in each ear). Analyses of quantita-
tive and qualitative data were performed. In the quanti-
tative data analysis, the mean, median and standard de-
viation for each parameter analyzed were calculated and 
the between groups comparison of means was conduct-
ed. The standard tests, Anderson-Darling and the Con-
fidence Interval for the Mean, were used for the statisti-
cal analysis of quantitative data. Regarding the qualitative 
data, the results were classified into normal and abnor-
mal and further classified into types of abnormalities. The 
Fisher Exact Test and the Confidence Interval for Propor-
tion were used for the statistical analysis of the qualita-
tive data with a significance level of 0.05 (5%). The con-
fidence intervals of the study were calculated with a 95% 
statistical confidence.
RESULTS
The analyses of qualitative and quantitative data ob-
tained from the electrophysiological hearing evaluation 
of the two groups are presented in this section. The BAEP 
values obtained from the right and left ears were pooled 
once no statistically significant differences for the vari-
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ables studied were observed in the comparison between 
ears in either group.
Statistically significant differences were observed be-
tween the control and research groups for latencies of 
waves III and V and interpeaks I-III and I-V, with high-
er values for the RG (Table 1). In the analysis of the qual-
itative data, the RG presented significantly higher occur-
rence of abnormal results than the CG (Table 2). Higher 
occurrence of abnormalities of LB type (41%), HB type 
and both abnormality types (29.5%) was observed.
Regarding the AMLR quantitative data analysis, no 
statistically significant differences between groups were 
observed for either latency of wave Pa or Na-Pa ampli-
tude. However, there were statistically significant differ-
ences for the Na wave latency in the derivations C3/A1, 
C4/A1 and C4/A2 (Table 3). The qualitative analysis of the 
Na - Pa amplitude (Table 4) demonstrated a greater per-
centage of abnormal results in the RG with no statistical-
ly significant difference between groups. The abnormali-
ties most frequently observed in the CG were both (43%) 
and, in the RG, the most frequently observed abnormali-
ties were ear effect (36%) and electrode effect (36%). The 
RG also showed a higher occurrence of abnormalities in 
latencies of Na and Pa waves and latency delay was the 
most frequently observed abnormality. 
For the P300 quantitative analysis, CG presented a 
mean latency of 313.27 ms and the RG presented a mean 
latency of 312.24 ms with no statistically significant differ-
ence between groups for this parameter (p-value=0.853).
There was no statistically significant difference be-
tween groups when comparing the occurrence of nor-
mal and abnormal results (Table 5), however, it was ob-
served a higher percentage of abnormal results for the 
Table 1. Between groups comparison of BAEP mean values of 
absolute latencies of waves I, III and V and interpeaks I-III, III-V and I-V.
BAEP Mean SD p-value
Wave I CG
RG
1.53
1.53
0.07
0.13
0.754
Wave III CG
RG
3.57
3.72
0.09
0.31
0.003*
Wave V CG
RG
5.50
5.78
0.45
0.37
0.005*
Interpeak I-III CG
RG
2.04
2.21
0.06
0.26
0.005*
Interpeak III-V CG
RG
1.98
2.03
0.08
0.27
0.264
Interpeak I-V CG
RG
4.03
4.26
0.06
0.35
0.005*
BAEP: brainstem auditory evoked potential; CG: control group; RG: research 
group; SD: standard deviation; *p-value statistically significant.
Table 2. Distribution of the occurrence of normal and abnormal 
BAEP results in control and research groups.
AEP
CG RG
p-valueN % N %
BAEP
Normal
Abnormal
25
0
100
0
8
17
32
68
<0.01
BAEP: brainstem auditory evoked potential; AEP: auditory evoked potential; 
CG: control group; RG: research group.
Table 3. Between groups comparison of AMLR mean latency values of waves Na and Pa (in ms) and Na-Pa amplitude (in microvolts) in the 
derivations C3/A1, C3/A2, C4/A1, C4/A2.
AMLR
C3/A1 C3/A2 C4/A1 C4/A2
CG RG CG RG CG RG CG RG
Na Latency 
  Mean
  Median
  SD
18.13
17.43
2.6
21.84
20.86
4.2
18.53
17.19
2.4
21.92
21.36
5.2
18.09
17.76
2.77
22.35
21.02
4.8
17.52
16.99
2.05
22.57
17.72
5.3
  p-value 0.036* 0.72 0.045* 0.025*
Pa Latency
  Mean
  Median
  SD
31.95
31.90
2.34
28.53
29.43
4.5
30.90
30.34
3.31
28.42
29.34
4.8
31.09
32.02
4.04
27.56
27.79
4.3
30.31
30.71
3.21
28.58
24.03
4.7
  p-value 0.84 0.66 0.75 0.44
Na-Pa Amplitude
  Mean
  Median
2.57
1.61
1.99
1.45
4.23
1.48
3.33
1.62
3.43
1.76
1.96
1.84
2.00
1.63
1.51
1.45
  p-value 0.561 0.759 0.451 0.331
AMLR: auditory middle latency response; CG: control group; RG: research group; SD: standard deviation; *p-value statistically significant.
RG. The type of abnormality most frequently found was 
the latency delay of the P300 wave (75%).
DISCUSSION
Auditory evoked potentials are important because 
they provide information regarding the functional and 
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structural integrity of the neural components of the au-
ditory pathway. In the present study, electrophysiological 
assessment of hearing was performed through auditory 
evoked potential measurements in individuals with MS. 
The AEP can provide an objective measurement on the 
integrity of the auditory system as a whole18, thus reaf-
firming the importance of such measures in neuroscience.
Authors report that the use of evoked responses can 
provide a sensitive index of MS when compared to CT 
or even MRI19,20. Abnormalities in AEP can be identi-
fied in patients with normal MRI, especially in the case 
of the brain stem. Moreover, it is important to consider 
that such diagnostic methods assess different features of 
the CNS (functional versus structural; sensory pathways 
versus CNS as a whole), therefore, they are complemen-
tary. The relatively high cost of MRI, when compared to 
AEP, is an additional issue to consider regarding the clin-
ical application of these two neurodiagnostic approach-
es in MS patients. 
Research indicates that improvement of MS symptoms 
has been related to changes in sensory evoked respons-
es9-11. This suggests that such procedures may be used 
to evaluate the effectiveness of treatment strategy, per-
haps with more sensitivity and objectivity than neurolog-
ical examination21. Additionally, MRI only evaluates the 
morphological data regarding the evolution of the disease 
in relation to the temporal and spatial aspects but does 
not offer information about the impact of therapy in MS. 
The BAEP allows the identification of possible brain-
stem abnormalities. These measures are important in aid-
ing neurological diagnosis once they have well-established 
criteria and a generator set. In the analysis of results ob-
tained on the BAEP, we observed that the individuals with 
MS showed significantly.
longer latency values and significantly higher occur-
rence of abnormal results (68%) when compared to the 
CG. Similar results were obtained by Celebisoy et al.4, 
who observed BAEP abnormalities in 60% of assessed in-
dividuals with MS. These analyses suggest the presence of 
abnormalities on the lower brainstem auditory pathway 
of individuals with MS. This is consistent with the study 
by Bergamaschi et al.5 who described the presence of ab-
normalities on the distal portion of the auditory nerve 
in patients with MS using MRI. Such results corrobo-
rate the findings of Hall3 regarding the electrophysiolog-
ical abnormalities that may be observed in BAEP in cas-
es of MS. These abnormalities may include increased la-
tencies of waves III and V, increased I-III, III-V and I-V 
interpeaks, the absence of one or more components, and 
poor reproducibility and morphology of the later compo-
nents suggesting dyssynchrony.
BAEP abnormalities were also reported by Santos et 
al.6. The authors observed BAEP abnormality in 58.62% 
of the individuals with MS with no signs of brainstem in-
volvement according to the MRI. The types of abnormali-
ties observed were poor wave morphology, increased I-V 
interpeak, the presence of only wave I, or the absence of 
the latest waves with normal first absolute latencies. Lima 
et al.22 also reported BAEP abnormalities in 36% of indi-
viduals with MS. 
Therefore, data found in this and in other studies4-7 
reinforce the importance of recording the BAEP in cas-
es of clinical suspicion of demyelinating diseases and es-
pecially with proven diagnosis of MS, because BAEP re-
cording aids in the diagnosis and the definition of the type 
of brain impairment presented. Moreover, the record can 
provide information about the functional aspect of im-
provement after treatment. As BAEP is an objective, easy 
and inexpensive method, it can be performed serially to 
evaluate the effectiveness of treatment. This is difficult to 
accomplish with MRI given its high cost. 
Table 4. Distribution of the occurrence of normal and abnormal AMLR results in control and research 
groups. 
AMLR
CG RG
p-valueN % N %
Na Latency Normal
Abnormal
21
4
84
16
2
23
8
92
<0.01*
Pa Latency Normal
Abnormal
20
5
80
20
23
2
8
92
0.42
Na-Pa Amplitude Normal
Abnormal
18
7
72
28
11
14
44
56
0.08
AMLR: auditory middle latency response; CG: control group; RG: research group; *p-value statistically significant.
Table 5. Distribution of the occurrence of normal and abnormal 
P300 results in control and research groups.
AEP
CG RG
p-valueN % N %
P300
Normal 25 100 21 84
0.11
Abnormal 0 0 4   16    
AEP: auditory evoked potential; CG: control group; RG: research group.
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The AMLR is considered one of the best tests to eval-
uate the central auditory nervous system, and it is also a 
useful tool in the design and monitoring of the therapeu-
tic process. There are few studies in the literature that use 
the AMLR as an electrophysiological measure for the in-
vestigation of the auditory pathway in patients with MS. 
In the present study, RG presented higher incidence of 
abnormal results than the CG with respect to the Na - Pa 
amplitude and the latencies of Pa and Na waves. Howev-
er, this difference was not statistically significant. The ab-
normalities of higher occurrence in the RG were ear ef-
fect, electrode effect, and delay in latencies of Pa and Na 
waves. The presence of AMLR abnormalities in individ-
uals with MS was also evidenced by Celebisoy et al.4 who 
reported the occurrence of abnormalities in 73.4% of indi-
viduals assessed. AMLR abnormalities were also observed 
in the MS case study presented by Schochat et al.7, thus 
demonstrating the possibility of involvement of the audi-
tory pathway at the subcortical level.
The latency of the P300 wave is the most reliable in-
dex for analysis of this potential17. Statistically significant 
differences between groups were not observed in either 
the qualitative or quantitative analysis. However, regard-
ing the distribution of normal and abnormal results, it 
was observed that the RG showed higher percentage of 
abnormal results than the CG. The latency delay was the 
type of abnormality most frequently observed.
The findings of this study regarding the presence of 
P300 abnormalities in individuals with MS and the types 
of abnormalities often encountered, corroborate those 
described by Schochat et al.7, Magnano et al.8, Giesser 
et al.23, Gonzáles-Rosa et al.24, Newton et al.25, Gil et al.26, 
and Dijk et al.27.
Several studies8-11,18,23,24,28 describe the presence of cog-
nitive changes in patients with MS demonstrating that 
they may present dysfunctions in memory, attention, ver-
bal fluency, task performance, and visual perception, all 
of which are important skills related to P300. These data 
justify the use of this potential, in association with oth-
er tests, in evaluation and follow-up of MS as reported 
by Magnano et al.8, Aminoff and Goodin9, Magnié et al.10 
and Kurokawa et al.29. In MS, the CNS electrophysiolog-
ical evaluations performed through visual evoked poten-
tials, auditory evoked potentials of short latency, and so-
matosensory potentials are well-established. 
Although the visual and somatosensory evoked po-
tentials have greater sensitivity than the AEP, the use 
of a multimodal battery promotes increased sensitivity 
when compared to using a single modality alone. Thom-
as30 states that when used in combination with structur-
al and functional MRIs, the electrophysiological mea-
sures can provide additional information regarding the 
temporal dynamics of brain activity. Moreover, accord-
ing to Aminoff and Goodin9 and Stockard and Rossiter21, 
there is a relationship between improvement of symp-
toms and reversal of abnormalities in somatosensory po-
tential, suggesting that this potential could be used in as-
sessing the effectiveness of medical treatment. Further-
more, the AMLR and event-related potentials have been 
widely studied because of their correlation with cognitive 
aspects. The abnormalities observed in these potentials 
are defined by the increase of the latency waves or by the 
absence of characteristic peaks6.
Thus, considering that individuals with MS may pres-
ent abnormalities in AEP and this procedure is both in-
expensive and easy to implement, we would like to em-
phasize that AEP can be considered by neurologists as an 
additional useful tool in assessing and monitoring of in-
dividuals with MS.
In conclusion, individuals with MS of the remittent-
recurrent type present abnormalities in BAEP. This sug-
gests that the brainstem auditory pathway, in the regions 
from the cochlear nucleus to the lateral lemniscus, may 
be disrupted due to structural and/or functional chang-
es in the transmission of the acoustic stimulus along the 
auditory pathway. Abnormalities in AMLR suggest im-
pairment in subcortical regions of the auditory pathway 
and/or central auditory processing disorder. The presence 
of abnormalities in cognitive potential (P300) suggests 
impairment in cortical regions of the auditory pathway 
and deficits in cognitive processing, memory, attention 
and auditory discrimination. Taking into consideration 
these aspects and the fact these individuals have hearing 
thresholds within normal limits, the combination of dif-
ferent objective methods of electrophysiological assess-
ment of hearing (BAEP, AMLR and P300) contributes to 
the detection of changes in central auditory pathway in 
individuals with MS.
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